Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil

Detalhes bibliográficos
Autor(a) principal: Sartorão-Filho,Carlos Izaias
Data de Publicação: 2022
Outros Autores: Zoqui,Mariana Costa, Duarte,Douglas Otomo, Ribeiro,Edy Alyson, Bisetto,Vinicius César Queiroz, Cachoni,Lara Escobar Gavião, Sartorão,Ana Luísa Varrone, Terribile,Diogo Coutinho, Mello,Beatriz Balsimelli de, Sartorão-Neto,Carlos Izaias, Mello,Roberto de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219
Resumo: ABSTRACT BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.
id APM-1_430c473f15eafd3870b8735997d64abe
oai_identifier_str oai:scielo:S1516-31802022005021219
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of BrazilCOVID-19Vaccination hesitancyVaccinationVaccination refusalAnti-vaccination movementCoronavirus disease 19Immunization, activeAnti-vaccine groupsABSTRACT BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.Associação Paulista de Medicina - APM2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219Sao Paulo Medical Journal n.ahead 2022reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2022.0095.r1.06072022info:eu-repo/semantics/openAccessSartorão-Filho,Carlos IzaiasZoqui,Mariana CostaDuarte,Douglas OtomoRibeiro,Edy AlysonBisetto,Vinicius César QueirozCachoni,Lara Escobar GaviãoSartorão,Ana Luísa VarroneTerribile,Diogo CoutinhoMello,Beatriz Balsimelli deSartorão-Neto,Carlos IzaiasMello,Roberto deeng2022-08-24T00:00:00Zoai:scielo:S1516-31802022005021219Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2022-08-24T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
spellingShingle Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
Sartorão-Filho,Carlos Izaias
COVID-19
Vaccination hesitancy
Vaccination
Vaccination refusal
Anti-vaccination movement
Coronavirus disease 19
Immunization, active
Anti-vaccine groups
title_short Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_full Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_fullStr Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_full_unstemmed Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_sort Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
author Sartorão-Filho,Carlos Izaias
author_facet Sartorão-Filho,Carlos Izaias
Zoqui,Mariana Costa
Duarte,Douglas Otomo
Ribeiro,Edy Alyson
Bisetto,Vinicius César Queiroz
Cachoni,Lara Escobar Gavião
Sartorão,Ana Luísa Varrone
Terribile,Diogo Coutinho
Mello,Beatriz Balsimelli de
Sartorão-Neto,Carlos Izaias
Mello,Roberto de
author_role author
author2 Zoqui,Mariana Costa
Duarte,Douglas Otomo
Ribeiro,Edy Alyson
Bisetto,Vinicius César Queiroz
Cachoni,Lara Escobar Gavião
Sartorão,Ana Luísa Varrone
Terribile,Diogo Coutinho
Mello,Beatriz Balsimelli de
Sartorão-Neto,Carlos Izaias
Mello,Roberto de
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sartorão-Filho,Carlos Izaias
Zoqui,Mariana Costa
Duarte,Douglas Otomo
Ribeiro,Edy Alyson
Bisetto,Vinicius César Queiroz
Cachoni,Lara Escobar Gavião
Sartorão,Ana Luísa Varrone
Terribile,Diogo Coutinho
Mello,Beatriz Balsimelli de
Sartorão-Neto,Carlos Izaias
Mello,Roberto de
dc.subject.por.fl_str_mv COVID-19
Vaccination hesitancy
Vaccination
Vaccination refusal
Anti-vaccination movement
Coronavirus disease 19
Immunization, active
Anti-vaccine groups
topic COVID-19
Vaccination hesitancy
Vaccination
Vaccination refusal
Anti-vaccination movement
Coronavirus disease 19
Immunization, active
Anti-vaccine groups
description ABSTRACT BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-3180.2022.0095.r1.06072022
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal n.ahead 2022
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209269032419328